Use este identificador para citar ou linkar para este item:
|Título:||A new animal model of intestinal mucositis induced by the combination of irinotecan and 5‑fluorouracil in mic|
|Autor(es):||Pereira, Venúcia B. M.|
Melo, Anielle T.
Assis‑Júnior, Eudmar M.
Wong, Deysi V. T.
Brito, Gerly A. C.
Almeida, Paulo R. C.
Ribeiro, Ronaldo A.
Lima‑Júnior, Roberto C. P.
|Data do documento:||2016|
|Editor:||Cancer Chemotherapy and Pharmacology|
|Citação:||PEREIRA, V. B. M. ; MELO, A. T. ; ASSIS-JUNIOR, E. M. ; WONG, D. V. T. ; BRITO, G. A. C. ; ALMEIDA, P. R. C. ; RIBEIRO, R. A. ; LIMA-JUNIOR, R. C. P. (2016)|
|Abstract:||Purpose Intestinal mucositis (IM) is a common side effect of anticancer agents. Despite polychemotherapy use in clinical practice, the pathogenesis of IM has been investigated in single drug injection animal models. However, the progression of IM could vary according to drug regimens. Thus, we aimed to develop a new experimental mucositis model induced by combining irinotecan and 5-fluorouracil (5-FU) treatments. Methods IM was induced in male C57BL/6 mice by the intraperitoneal administration of either 0.9 % saline (5 mL/ kg), irinotecan (IRI, 30 or 45 mg/kg), 5-FU (25, 37.5, or 50 mg/kg), or the combination of these doses (IRI + 5-FU) for 4 days. Animal survival, body mass variation, and diarrhea scores were evaluated daily. On the 7th day, the mice were euthanized, and intestinal samples were collected for histopathology and morphometric analysis, as well as for the determination of myeloperoxidase activity and cytokine dosage (TNF-α and IL-6). Results The optimal dose combination that induced IM and presented no substantial mortality on the 7th day was IRI (45 mg/kg) + 5-FU (37.5 mg/kg), which was used for subsequent studies. IRI and 5-FU in combination induced significant diarrhea, body weight loss, intestinal damage, inflammatory cell infiltration, and increased levels of cytokines when compared with other groups (P < 0.05). Neither IRI nor 5-FU alone induced IM. Conclusions We developed a new experimental model of IM induced by combining irinotecan and 5-FU treatments, which will allow us to gain a better knowledge concerning the pathogenesis of this disease through the pharmacological modulation of key inflammatory mediators.|
|Descrição:||PEREIRA, Venúcia B. M. et al. A new animal model of intestinal mucositis induced by the combination of irinotecan and 5‑fluorouracil in mice. Cancer Chemother Pharmacol, Berlin, v. 77, p. 323–332, 2016.|
|Aparece nas coleções:||DFIFA - Artigos publicados em revista científica|
Arquivos associados a este item:
|2016_art_vbmpereira.pdf||976,71 kB||Adobe PDF||Visualizar/Abrir|
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.